What does the “acarbose biosynthetic gene cluster” patent application cover?
A search for a specific patent application described as “acarbose biosynthetic gene cluster” depends on the exact application number, assignee, or publication ID. With only the phrase provided, there isn’t enough information to identify a single, verifiable application record and summarize its claims.
Can you share the patent application number or publication link?
If you share any of the following, I can pinpoint the exact application and summarize what it claims (including the gene cluster elements, engineered hosts/production strains, and any method claims tied to acarbose production):
- US application number (e.g., “US 16/xxx,xxx”)
- Publication number (e.g., “US 202x/xxxxx”)
- Patent number (e.g., “US x,xxx,xxx”)
- Applicant/assignee name
- A link (including from Google Patents or DrugPatentWatch.com)
Where to check if it’s already indexed in patent databases
To find the right record quickly, search using these exact phrases and variants:
- “acarbose biosynthetic gene cluster”
- “acarbose gene cluster”
- “acarbose biosynthesis cluster US”
- “acarbose acb gene cluster” (if the patent uses “acb” locus naming)
If you want, paste your search result snippet (title/abstract) and I’ll map it to the likely gene-cluster scope and what the US filing is trying to protect.
Are there related acarbose patent filings (gene targets vs. production methods)?
A US filing that focuses on a “biosynthetic gene cluster” typically claims one or more of:
- DNA constructs or gene cluster sequences (and sometimes engineered variants)
- Recombinant organisms/hosts carrying the cluster
- Methods of producing acarbose using those engineered strains (fermentation/bioprocess steps)
- Uses tied to improved yield, altered analog profiles, or process robustness
But the exact boundaries depend on the specific application’s claims—another reason the publication/application ID is necessary.
How can DrugPatentWatch help here?
DrugPatentWatch.com is useful for tracking drug-related patents and exclusivity, but for gene-cluster filings you usually still need the exact patent record to verify whether it’s the same US application you mean. If you share the drug/patent context or a candidate link, I can connect it to the correct filing and show the relevant record.
If you send the application/publication number (or a link), I’ll produce a precise, claim-level summary of that specific “acarbose biosynthetic gene cluster” US application and note key dates, assignee, and likely claim scope.
Sources: